Home/Filings/4/0001628908-23-000035
4//SEC Filing

Shams Aammaad 4

Accession 0001628908-23-000035

CIK 0001628908other

Filed

Mar 2, 7:00 PM ET

Accepted

Mar 3, 5:32 PM ET

Size

6.7 KB

Accession

0001628908-23-000035

Insider Transaction Report

Form 4
Period: 2023-03-01
Shams Aammaad
Chief Accounting Officer
Transactions
  • Award

    Class A Common Stock

    2023-03-01+16,00052,884 total
  • Tax Payment

    Class A Common Stock

    2023-03-01$35.26/sh672$23,69552,212 total
Footnotes (4)
  • [F1]Represents restricted stock units granted to Mr. Shams pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.
  • [F2]Securities vest at a rate of 34% on March 1, 2024, and 33% on March 1, 2025, and March 1, 2026.
  • [F3]Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
  • [F4]This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units.

Issuer

Evolent Health, Inc.

CIK 0001628908

Entity typeother

Related Parties

1
  • filerCIK 0001815354

Filing Metadata

Form type
4
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 5:32 PM ET
Size
6.7 KB